Minova Life Science

Minova life sciences - Pharmaceutical company


A Gift Worth Protecting is Clear Vision



  • Acute bacterial conjunctivitis (conjunctivitis)
  • Bacterial keratitis


  • A novel fourth-generation fluoroquinolone
  • Acts by interfering with the bacterial DNA replication process
  • Known to be highly effective against both gram-positive and negative organisms


  • A bactericidal drug that acts by primarily inhibiting protein synthesis
  • Useful in controlling both superficial and deep infections of the eye and ocular adnexa
  • In a study about antibiotic resistance in bacteria causing eye infections, it was found S. aureus’s resistance to tobramycin had decreased little but significantly.


  • Both Tobramycin and Moxifloxacin in eye drops are equally effective as empirical therapy when used in acute bacterial conjunctivitis
  • High rates of clinical cure were achieved with both agents with negligible side effects.

Explore other products

Scroll to Top